Fundamentals

Valuation

Metric	Q2	Q3	Δ in %
EV/EBITDA	-18.95	56.84	70.13
Graham Fair Price	20.38	27.06	22.48
PEG	-94.73	0.60	11.39
Price/Book	-2.83	21.54	22.17
Price/Cash Flow	-30.23	74.32	106.53
Prices/Earnings	-22.84	21.03	27.25
Price/Sales	-11.99	18.97	21.55
Price/FCF	-30.23	74.32	106.53
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q2	Q3	Δ in %
Gross Profit Margin	11.74	0.47	0.42
Operating Margin	4.56	0.29	0.28
ROA	19.94	0.02	0.02
ROE	0.20	0.26	25.94
ROIC	0.08	0.09	8.27
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q2	Q3	Δ in %
Debt QOQ	< 0.005	< 0.005	-142.77
Dividends QOQ	< 0.005	0.12	4717.02
EBIT QOQ	0.07	0.24	257.02
EPS QOQ	0.02	0.35	1364.95
FCF QOQ	3.49	0.49	-85.91
Revenue QOQ	0.03	0.18	496.21
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q2	Q3	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	1493.53	1558.29	4.34
Days Sales Outstanding (DSO)	68.32	59.28	-13.22
Inventory Turnover	0.06	0.06	-4.16
Debt/Capitalization	0.62	0.65	3.64
Quick Ratio	0.10	0.12	17.42
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q2	Q3	Δ in %
Book Value	10.51	11.27	7.27
Cash	4.05	8.02	97.91
Capex	-0.32	-0.38	-17.85
Free Cash Flow	2.19	3.27	49.40
Revenue	10.81	12.80	18.43
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q2	Q3	Δ in %
Current Ratio	1.01	1.01	0.41
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	1.21	< 0.005	-99.62
Naive Interpretation	Member

06 - Financial Health · Bad

Rating